HCA Healthcare, Inc. (NYSE:HCA) Shares Bought by Mitsubishi UFJ Asset Management Co. Ltd.

Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 6.8% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 294,597 shares of the company’s stock after acquiring an additional 18,672 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. owned approximately 0.12% of HCA Healthcare worth $87,407,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of HCA. Whipplewood Advisors LLC purchased a new position in HCA Healthcare during the fourth quarter worth about $31,000. Tidemark LLC purchased a new stake in HCA Healthcare in the fourth quarter valued at approximately $36,000. Legacy Investment Solutions LLC purchased a new position in shares of HCA Healthcare during the third quarter worth $39,000. Activest Wealth Management lifted its stake in HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after acquiring an additional 125 shares in the last quarter. Finally, Pinnacle Bancorp Inc. grew its position in HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after acquiring an additional 50 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $341.94 on Friday. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The stock has a market cap of $84.19 billion, a P/E ratio of 15.56, a P/E/G ratio of 1.10 and a beta of 1.68. The stock has a 50 day moving average of $323.90 and a two-hundred day moving average of $341.86. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period last year, the firm earned $5.90 EPS. On average, research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a dividend yield of 0.84%. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.11%.

Insiders Place Their Bets

In related news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares in the company, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is owned by insiders.

Analyst Ratings Changes

Several brokerages recently weighed in on HCA. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $405.00 target price on shares of HCA Healthcare in a research note on Monday, January 27th. KeyCorp reduced their price objective on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $380.00 price target on shares of HCA Healthcare in a research report on Tuesday, December 17th. Truist Financial reduced their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Finally, Morgan Stanley dropped their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 17th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $385.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.